Your browser doesn't support javascript.
loading
Inositol monophosphatase 1 (IMPA1) promotes triple-negative breast cancer progression through regulating mTOR pathway and EMT process.
Yang, Shao-Ying; Xie, Yi-Fan; Zhang, Tai-Mei; Deng, Ling; Liao, Li; Hu, Shu-Yuan; Zhang, Yin-Ling; Zhang, Fang-Lin; Li, Da-Qiang.
Afiliação
  • Yang SY; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Xie YF; Department of Breast Surgery, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang TM; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Deng L; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Liao L; Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China.
  • Hu SY; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Zhang YL; Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang FL; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Li DQ; Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China.
Cancer Med ; 12(2): 1602-1615, 2023 01.
Article em En | MEDLINE | ID: mdl-35796646
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China